Correlation Between Merck and BetterLife Pharma
Can any of the company-specific risk be diversified away by investing in both Merck and BetterLife Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and BetterLife Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and BetterLife Pharma, you can compare the effects of market volatilities on Merck and BetterLife Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of BetterLife Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and BetterLife Pharma.
Diversification Opportunities for Merck and BetterLife Pharma
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Merck and BetterLife is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and BetterLife Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BetterLife Pharma and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with BetterLife Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BetterLife Pharma has no effect on the direction of Merck i.e., Merck and BetterLife Pharma go up and down completely randomly.
Pair Corralation between Merck and BetterLife Pharma
Considering the 90-day investment horizon Merck Company is expected to under-perform the BetterLife Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 7.38 times less risky than BetterLife Pharma. The stock trades about -0.07 of its potential returns per unit of risk. The BetterLife Pharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 7.50 in BetterLife Pharma on December 28, 2024 and sell it today you would lose (0.82) from holding BetterLife Pharma or give up 10.93% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.36% |
Values | Daily Returns |
Merck Company vs. BetterLife Pharma
Performance |
Timeline |
Merck Company |
BetterLife Pharma |
Merck and BetterLife Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merck and BetterLife Pharma
The main advantage of trading using opposite Merck and BetterLife Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, BetterLife Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BetterLife Pharma will offset losses from the drop in BetterLife Pharma's long position.Merck vs. Emergent Biosolutions | Merck vs. Bausch Health Companies | Merck vs. Neurocrine Biosciences | Merck vs. Teva Pharma Industries |
BetterLife Pharma vs. Biotron Limited | BetterLife Pharma vs. biOasis Technologies | BetterLife Pharma vs. Covalon Technologies | BetterLife Pharma vs. Mosaic Immunoengineering |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |